Talk:National Bleeding Disorders Foundation

Medicine: Hematology-oncology / Genetics Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Low	This article has been rated as Low-importance on the project's importance scale.
	This article is supported by the Hematology-oncology task force.
	This article is supported by the Medical genetics task force.

Organizations Low‑importance

	This article is within the scope of WikiProject Organizations, a collaborative effort to improve the coverage of Organizations on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.OrganizationsWikipedia:WikiProject OrganizationsTemplate:WikiProject Organizationsorganization articles
Low	This article has been rated as Low-importance on the project's importance scale.

Requested move 19 August 2023[edit]

The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review after discussing it on the closer's talk page. No further edits should be made to this discussion.

The result of the move request was: Moved. (non-admin closure) Adumbrativus (talk) 04:09, 27 August 2023 (UTC)[reply]

National Hemophilia Foundation → National Bleeding Disorders Foundation – Why ... the organization has rebranded. Ahagen4 (talk) 15:24, 19 August 2023 (UTC)[reply]

Support - This checks out. Schierbecker (talk) 00:54, 25 August 2023 (UTC)[reply]

The discussion above is closed. Please do not modify it. Subsequent comments should be made on the appropriate discussion page. No further edits should be made to this discussion.